Clinical significance of tumour mutation burden in immunotherapy across multiple cancer types: an individual meta-analysis.
Sign Up to like & getrecommendations! Published in 2020 at "Japanese journal of clinical oncology"
DOI: 10.1093/jjco/hyaa076
Abstract: BACKGROUND Biomarkers for stratifying patients that could benefit from immune checkpoint inhibitors are necessary. Tumour mutation burden has recently become a promising biomarker in cancer, but the associations between tumour mutation burden and outcomes of… read more here.
Keywords: cancer; tumour mutation; mutation burden; meta analysis ... See more keywords
A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Cellular and Molecular Medicine"
DOI: 10.1111/jcmm.15762
Abstract: Current studies have shown that long non‐coding RNAs (lncRNAs) may serve as prognostic biomarkers in multiple cancers. Therefore, we postulated that expression patterns of multiple lncRNAs combined into a single signature could improve clinicopathological risk… read more here.
Keywords: tumour mutation; breast cancer; mutation burden; signature ... See more keywords